These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 18413364)

  • 1. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.
    Wang XJ; Sun Z; Villeneuve NF; Zhang S; Zhao F; Li Y; Chen W; Yi X; Zheng W; Wondrak GT; Wong PK; Zhang DD
    Carcinogenesis; 2008 Jun; 29(6):1235-43. PubMed ID: 18413364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of Nrf2 determine chemoresistance in type II endometrial cancer.
    Jiang T; Chen N; Zhao F; Wang XJ; Kong B; Zheng W; Zhang DD
    Cancer Res; 2010 Jul; 70(13):5486-96. PubMed ID: 20530669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory role of KEAP1 and NRF2 in PPARĪ³ expression and chemoresistance in human non-small-cell lung carcinoma cells.
    Zhan L; Zhang H; Zhang Q; Woods CG; Chen Y; Xue P; Dong J; Tokar EJ; Xu Y; Hou Y; Fu J; Yarborough K; Wang A; Qu W; Waalkes MP; Andersen ME; Pi J
    Free Radic Biol Med; 2012 Aug; 53(4):758-68. PubMed ID: 22684020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
    Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
    PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.
    Ren D; Villeneuve NF; Jiang T; Wu T; Lau A; Toppin HA; Zhang DD
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1433-8. PubMed ID: 21205897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.
    Shibata T; Ohta T; Tong KI; Kokubu A; Odogawa R; Tsuta K; Asamura H; Yamamoto M; Hirohashi S
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13568-73. PubMed ID: 18757741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.
    Khatri R; Shah P; Guha R; Rassool FV; Tomkinson AE; Brodie A; Jaiswal AK
    Mol Cancer Ther; 2015 Jul; 14(7):1728-37. PubMed ID: 25976679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
    Shibata T; Kokubu A; Gotoh M; Ojima H; Ohta T; Yamamoto M; Hirohashi S
    Gastroenterology; 2008 Oct; 135(4):1358-1368, 1368.e1-4. PubMed ID: 18692501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies.
    Hu L; Miao W; Loignon M; Kandouz M; Batist G
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):467-74. PubMed ID: 19940992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells.
    Panieri E; Saso L
    Antioxid Redox Signal; 2021 Jun; 34(18):1428-1483. PubMed ID: 33403898
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-regulations among NRFs and KEAP1 and effects of their silencing on arsenic-induced antioxidant response and cytotoxicity in human keratinocytes.
    Zhao R; Hou Y; Zhang Q; Woods CG; Xue P; Fu J; Yarborough K; Guan D; Andersen ME; Pi J
    Environ Health Perspect; 2012 Apr; 120(4):583-9. PubMed ID: 22476201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance.
    Jeddi F; Soozangar N; Sadeghi MR; Somi MH; Samadi N
    DNA Repair (Amst); 2017 Jun; 54():13-21. PubMed ID: 28415030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of chemical activation of Nrf2.
    Li Y; Paonessa JD; Zhang Y
    PLoS One; 2012; 7(4):e35122. PubMed ID: 22558124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.
    Zhang P; Singh A; Yegnasubramanian S; Esopi D; Kombairaju P; Bodas M; Wu H; Bova SG; Biswal S
    Mol Cancer Ther; 2010 Feb; 9(2):336-46. PubMed ID: 20124447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance.
    Niture SK; Jaiswal AK
    Free Radic Biol Med; 2013 Apr; 57():119-31. PubMed ID: 23275004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of the Nrf2-Keap1 signaling pathway in cancer.
    Jaramillo MC; Zhang DD
    Genes Dev; 2013 Oct; 27(20):2179-91. PubMed ID: 24142871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP15 negatively regulates Nrf2 through deubiquitination of Keap1.
    Villeneuve NF; Tian W; Wu T; Sun Z; Lau A; Chapman E; Fang D; Zhang DD
    Mol Cell; 2013 Jul; 51(1):68-79. PubMed ID: 23727018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nrf2 down-regulated cell line H460-N5 with Keap1 over-expression increased sensitivity to anti-cancer drugs].
    Qu LY; Gao P; Wang HY; Wang XJ; Tang XW
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 39(1):6-10. PubMed ID: 20175229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells.
    Kim WD; Kim YW; Cho IJ; Lee CH; Kim SG
    J Cell Sci; 2012 Mar; 125(Pt 5):1284-95. PubMed ID: 22302998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic-mediated activation of the Nrf2-Keap1 antioxidant pathway.
    Lau A; Whitman SA; Jaramillo MC; Zhang DD
    J Biochem Mol Toxicol; 2013 Feb; 27(2):99-105. PubMed ID: 23188707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.